Skip to content

Friday, 13 November 2026

Hims & Hers Stock Just Plummeted 17%. Is the Stock a Buy Ahead of a Peptide Push?

From The Motley Fool 13 Nov 2026, 17:40 UTC 1 min read

Hims & Hers Stock Just Plummeted 17%. Is the Stock a Buy Ahead of a Peptide Push? — Image: The Motley Fool

Hims & Hers stock crashed after issuing weak guidance.

Full story

Continue reading this story on The Motley Fool, the publisher that reported it.

Read the full story at The Motley Fool ↗

AI tools

Written by AI from the article text. It can make mistakes; check the original story.

Topics in this story

More from Business

See all

Business

Why York Space Systems Stock Just Crashed

37 min ago

Business

Anthropic Set Its IPO Share Price Range at $70 to $78, Valuing It at Up to $1.4 Trillion

46 min ago

Business

Jensen Quits. Fools Tackle Your Toughest Questions

46 min ago

Business

AppLovin vs. The Trade Desk: Which Is the Better Digital Advertising Stock to Buy Going Into 2027?

49 min ago

Business

Anthropic’s Valuation Target Has Slipped From $2 Trillion to Under $1.5 Trillion. Here’s Why

51 min ago

Business

Stock Market Midday, Nov. 13: Nasdaq Plunges as Nvidia Turmoil Deepens and Treasury Yields Hit 5%

51 min ago